The biological activities and mechanisms of action of individual transoctadecenoic acids (trans-18:1 FA) have not been completely elucidated. We examined the effects of several individual trans-18:1 FA isomers and trans-10, cis-12 conjugated linoleic acid (CLA) on fat synthesis, and expression of lipogenic genes in mammary and liver tissue in lactating mice. From d 6 to 10 postpartum, 30 lactating C57BL/6J mice were randomly assigned to either a control (CTR) diet containing 20 g/kg oleic acid or diets in which the oleic acid was either completely replaced by partially hydrogenated vegetable oil (PHVO), trans-7 18:1 (T7), trans-9 18:1 (T9), or trans-11 18:1 (T11) or partially replaced with 6.66 g/kg trans-10, cis-12 CLA. Milk fat percentage was decreased by CLA (44%), T7 (27%), and PHVO (23%), compared with CTR. In the mammary gland, CLA decreased the expression of genes related to de novo FA synthesis, desaturation, triacylglycerol formation, and transcriptional regulation.
Introduction
In the US, it is mandatory to list trans fatty acids (tFA) 8 on the nutrient labels of foods and dietary supplements due to their potential negative effects on human health. The transoctadecenoic acids (trans-18:1 FA) comprise 80-90% of tFA in food originating from ruminants, vegetable shortening, or margarines. Epidemiological studies show a direct relationship between industrially produced tFA and the risk of coronary heart disease but not with tFA derived from ruminants (1) . These effects could be associated with differences in their tFA isomer profile. Industrially derived tFA have a Gaussian trans-18:1 FA distribution, with trans-9 18:1 and trans-10 18:1 being the major isomers, whereas ruminant-derived tFA consists predominantly of trans-11 18:1 FA and smaller proportions of other trans-18:1 isomers.
The biological activities and mechanisms of action of individual trans-18:1 FA have not been completely elucidated (2) . The effects of trans-18:1 FA on milk fat synthesis in lactating mice fed partially hydrogenated vegetable oil (PHVO) were first reported by Teter et al. (3) . PHVO contain a mixture of positional trans-18:1 FA isomers ranging from trans-4-to trans-16-18:1. Few studies (4) have investigated the effects of individual trans-18:1 FA on milk fat synthesis or the subsequent effects on the nursing neonate in monogastric animals. Nonetheless, in lactating cows, individual trans-9-(5), trans-10-(6), trans-11-, and trans-12-18:1 (7) isomers were examined, but effects on milk fat synthesis were not observed. In addition to trans-18:1 FA isomers, conjugated linoleic acids (CLA) with a trans double bond, trans-10, cis-12-(8), trans-9, cis-11- (9) , and trans-7, cis-9-CLA (8), have shown a strong negative correlation to milk fat content. Of these, the role of trans-10, cis-12 CLA in decreasing milk fat synthesis is well established (10) .
Although, the mechanisms involved in milk fat depression (MFD) are not completely elucidated, studies in ruminants (11) and nonruminant (12) animals have shown that MFD is mainly characterized by a decrease in de novo FA synthesis due possibly to a decrease in mRNA abundance and enzymatic activity of mammary lipogenic enzymes. Rudolph et al. (13) have suggested regulation of lipid synthesis at the level of mRNA expression and indicated sterol regulatory element binding transcription factor 1c (SREBP-1c) as one of the regulators. Recently, we have shown that PPARg activation could upregulate lipogenic genes in mammary epithelial cells (14) . In addition to SREBP-1c, carbohydrate response element binding protein (ChREBP) is known to regulate lipogenic genes in liver (15) . Based on these findings, we hypothesized that the effects of dietary tFA on milk fat synthesis could be regulated through multiple transcriptional regulators in the mammary gland, similar to those in other lipogenic tissues. Our objectives were to examine the effects of several individual trans-18:1 FA isomers and trans-10, cis-12 CLA on fat synthesis, as well as the expression of lipogenic genes and transcription factors in mammary and liver tissues of lactating mice.
Materials and Methods
Mice, diets, and treatments. The experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Maryland, College Park. Timed pregnant multiparous female C56BL/6J mice were obtained from the Department of Animal and Avian Sciences, University of Maryland. Dams and their pups were housed in shoebox cages and consumed food and water ad libitum. Pregnant mice were fed a commercial rodent diet (5001 Rodent Lab Diet, Purina) consisting of 23% crude protein, 4.5% fat, and 6.0% fiber until 2 d before expected parturition. From d 2 prepartum until d 6 postpartum, dams were fed the control (CTR) diet. On d 6 postpartum, they were randomly assigned to 1 of the 6 treatment diets: CTR, PHVO, trans-10, cis-12 CLA, trans-7 18:1(T7), trans-9 18:1(T9), and trans-11 18:1 (T11). The composition of the diets ( Table 1 ) and FA in all the treatments were similar except for the test FA ( Table 2) . Oleic acid (cis-9 18:1) in the CTR diet was replaced completely with the respective tFA in the T7, T9, and T11 diets but was replaced at 30% in the CLA treatment, consistent with the documented potency of trans-10, cis-12 CLA (8). Litter size was adjusted to 6 or 7 pups to maintain uniform milk synthesis among dams. Lactating mice were fed the experimental diets from d 6 to d 10 postpartum.
Sample collection. Daily feed intake was recorded during the experimental period. On d 6 and 10 postpartum, milk samples were collected by suction and milk fat percentages measured as described by Teter et al. (3) . Milk fat percentages estimated by crematocrit as volume percentages were converted to weight percentages using calibration factors developed by Teter et al. (3) . The milk samples were stored at 2208C for FA analyses. Body weights of dams and pups were recorded before milking. On d 10 postpartum, the mice were killed using isoflurane and individual liver and mammary tissues were collected from dams and pooled livers from pups from each diet. The mammary and liver samples were flashfrozen in liquid N and stored at 2808C until RNA or lipid extraction.
FA analyses. Fats in the diets, milk, and lyophilized liver tissue samples were saponified with 0.5 mol/L NaOH in methanol for 30 min at 508C and esterified to FAME with 1.2 mol/L H 2 SO 4 in methanol using Trinonadecenoin (Nu-Chek Prep) as an internal standard. The diet and milk FAME were analyzed using a Hewlett Packard (HP 5890) gas chromatograph equipped with a 30-m 3 0.25-mm fused silica capillary column coated with SP-2380 (Supelco) and FID detector. The injector and detector temperatures were maintained at 2508C. The initial oven temperature was 1558C (held for 5 min) and was programmed to increase at a rate of 1.48C/min to a final temperature of 1958C (held for 10 min). Peak identification was based on relative retention times of 3 Cocoa butter, 14.3 g/kg; corn oil, 30.9 g/kg; olive oil, 34.8 g/kg; and oleic acid, 20 g/kg. 4 The oleic acid was replaced completely with trans-7 18:1, trans-9 18:1, and trans-11 18:1 in the T7, T9, and T11 diets, respectively, but at 30% with trans-10, cis-12 CLA in the CLA diet. 5 PHVO treatment consisted of vegetable shortening, 45.73 g/kg; corn oil, 26.6 g/kg; soybean oil, 7.6 g/kg; and oleic acid, 20 g/kg. 6 Composition of mineral and vitamin mix as described previously by Teter et al. (3) . 7 Sigma Chemical. commercial standards including GLC-68B and GLC-463 (Nu-Check Prep). Individual CLA isomers in milk and liver tissue FAME were analyzed as described previously (16) . A CLA standard mixture (NuChek Prep) spiked with trans-7, cis-9 CLA standard was used to identify individual CLA isomers.
RNA isolation and quantitative RT-PCR. Total RNA was isolated from ;1 g of tissue using Qiazol lysis reagent (QIAGEN) and RNeasy isolation kits with on-column DNAse digestion (QIAGEN). The RNA quality was evaluated using the Agilent 2100 Bioanalyzer with RNA 6000 Nano Labchip kits (Agilent Technologies) and concentrations were determined using the Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies 
Results
Feed intake, body and organ weights, and pup growth rate. The feed intake was reduced by supplementation of trans-10, cis-12 CLA (23%) but not with other tFA (Table 3) . Although dietary FA did not affect the body weights, liver weights were increased by the CLA (30%) and T7 (20%) diets, probably due to accumulation of FA (Table 3 ). The growth rate of pups from mice fed CLA was slower (P , 0.05) compared with other treatment groups. Growth was also reduced (P , 0.05) in pups whose dams were fed the T7, T9, and PHVO diets compared with the CTR diet (Table 3) .
Milk volume and fat percentage. Milk fat percentage (Table  3) was decreased by the CLA (41%; P , 0.001), T7 (26%; P , 0.05), and PHVO (23%; P , 0.05) diets compared with the CTR diet. Milk volume, calculated based on the mean litter body weight, was lower in dams fed CLA (39%; P , 0.05). These data must be interpreted with caution, because they may have been influenced by the lower litter body weight and the decrease in milk fat content in mice fed the CLA and T7 diets.
Milk FA composition. MFD is typically characterized by a reduction in the de novo synthesized FA [medium-chain (,16:0) FA +16:0] (12). Compared with the CTR diet, the CLA, PHVO, and T7 diets decreased total medium-chain FA by 41, 21, and 16%, respectively (Supplemental Table 2 ). However, 16:0 FA were reduced only by the CLA (20%; P , 0.01) and PHVO (13%; P , 0.05) diets ( Table 4 ).
The trans-18:1 FA and CLA isomers provided by the diets were taken up by the mammary gland and incorporated into milk fat (Table 4) . Total trans-18:1 FA was markedly increased in mice fed the trans-18:1-supplemented diets (Table 4) . Also, substantial amounts of trans-7 18:1 and trans-11 18:1 were desaturated to trans-7, cis-9 CLA and cis-9, trans-11 CLA in mice fed the T7 and T11 diets, respectively. Small amounts of trans-7, cis-9 CLA (0.08%) were also found in the milk of mice fed PHVO due to the presence of trans-7 18:1 in the diet. The trans-10, cis-12 CLA was the major milk FA isomer of mice fed the CLA diet and was not detected in any other treatments (Supplemental Table 3 ).
FA composition of dam liver. The CLA, PHVO, and T7 diets, those causing MFD, increased the total hepatic FAME concentration by 81, 35, and 38%, respectively, relative to the CTR diet ( Table 3 ). The increase in liver weight (Table 3) due to increased liver fat content suggested the development of fatty liver. Fatty liver is typically characterized by increases in 16:0, 16:1, and 18:1 FA but decreases in 18:0, 18:3(n-3), and 20:4(n-6) FA (17) and these changes occurred in the liver of mice fed the CLA, PHVO, and T7 diets (Supplemental Table 4 ). The dietary tFA taken up by the liver increased the total trans-18:1 FA content. Similar to mammary tissue, substantial amounts of trans-7 18:1 FA and trans-11 18:1 FA were desaturated to trans-7, cis-9 CLA and cis-9 trans-11 CLA, respectively, in mice fed the T7 and T11 diets (Supplemental Table 5 ).
Mammary lipogenic gene expression. Changes in milk fat content due to dietary FA were reflected in the mammary lipogenic gene expression profile. CLA-fed mice exhibiting maximum MFD had decreased the expression of genes involved in FA synthesis (FASN, ACACA), triacylglycerol (TAG) formation (AGPAT1), and FA desaturation (SCD1, SCD2) ( Table 5) . Among the trans-18:1 FA isomers, the mRNA abundance for FASN and AGPAT1 was lower (P , 0.05) in mice fed PHVO than in the CTR group, whereas that of AGPAT1 tended to be lower in mice fed the T7 diet (P = 0.07). SCD2 was upregulated only by the T7 diet (53%; P , 0.05). Mammary lipogenic genes were not affected by the T9 and T11 diets, consistent with a lack of change in milk fat content. Consistent with the decrease in large-scale lipogenic gene transcripts, the CLA diet decreased mRNA abundance of SREBP1c, ChREBP, THRSP, PPARa, and PPARg (P # 0.05). Similarly, PHVO decreased the expression of SREBP-1c, THRSP, and PPARa (P , 0.05) whereas the T7 diet decreased THRSP expression (P , 0.05) ( Table 5) .
Hepatic lipogenic gene expression. The hepatic lipogenic gene responses differed from that of mammary tissue (Supplemental Table 6 ). Compared with the CTR, PPARa expression tended to be increased (P = 0.07) with the CLA diet, suggesting oxidation of FA in the liver.
Discussion
Analysis of the relationship between individual trans-18:1 FA isomers and milk fat percentage has shown differences in their relative potency to reduce milk fat content (8) . In this study, we demonstrated that dietary supplementation of trans-7 18:1 reduces milk fat content in addition to other known tFA sources, PHVO (3), and trans-10, cis-12 CLA (12). Dietary trans-7 18:1 was taken up by the mammary and liver tissues and desaturated at D9, to trans-7, cis-9 CLA. To our knowledge, this is the first study to show direct conversion of dietary trans-7 18:1 to trans-7, cis-9 CLA in both mammary and hepatic tissue. We estimated that 58% of trans-7 18:1 was converted to trans-7, cis-9 CLA in the mammary tissue of mice fed trans-7 18:1. The estimates were calculated as the proportion of D9 desaturation product (trans-7, cis-9 CLA) originating from the total trans-18:1 precursor (sum of trans-7 18:1 and trans-7, cis-9 CLA) in milk. Due to substantial synthesis of trans-7, cis-9 CLA in mice fed trans-7 18:1, we speculate that the effect of trans-7 18:1 on milk fat synthesis might be mediated through trans-7, cis-9 CLA. We have previously reported that trans-7, cis-9 CLA and trans-10, cis-12 CLA were the isomers most negatively correlated to milk fat percentage (8) .
MFD is characterized by a reduction in de novo FA synthesis associated with a decrease in mRNA abundance of key lipogenic enzymes in the mammary gland (12) . We measured the milk FA profile and transcript abundance of lipogenic genes to delineate the differences in the ability of tFA to alter milk fat synthesis. The CLA diet decreased milk fat percentage (241%) by reducing de novo synthesized FA (C , 16:0 FA and C16:0) and downregulated the expression of lipogenic genes related to FA synthesis (ACACA, FASN), desaturation (SCD1, SCD2), TAG formation (AGPAT1), and transcriptional regulation, SREBP-1c, and ChREBP.
SREBP-1c is an important regulator in murine mammary lipid synthesis (13) known to regulate the expression of ACACA, FASN, and SCD1 (18) . Formation of active nuclear form of SREBP-1c is regulated both transcriptionally and posttranslationally (19) . In this study, while SREBP-1c mRNA expression was downregulated, transcript abundance of SCAP (21), and RXR, the binding partner of LXRA, were not affected, indicating that CLA effects were probably not mediated through these nuclear receptors. It is also possible that trans-10, cis-12 CLA could accelerate the transcript decay of SREBP-1c as observed with PUFA (22) . In addition to SREBP1c, ChREBP is known to coregulate the expression of lipogenic genes FASN and ACACA (14) . ChREBP is a glucose-responsive transcription factor regulated by both transcriptional (23) and post-translational activation (14) . The decreased transcript abundance of ChREBP in our study could be due to reduced glucose levels (14) as a consequence of reduced feed intake or increased mRNA decay, as reported for PUFA (24) . Our recent studies with mammary epithelial cells (MacT) suggested a role for PPARg in mammary lipid synthesis (15) . In this study, the mammary mRNA expression of PPARg was decreased with the CLA diet but not with the other diets. However, the expression of LPL, a known PPARg target gene, was not affected. This is in accordance with our earlier observations with MacT cells (15) . The expression of PPARa, a transcriptional regulator associated with upregulation of genes involved in FA oxidation, was also decreased with CLA, indicating that mammary FA oxidation is not a contributor to MFD. We observed a decrease in THRSP mRNA expression, proportional to the degree of MFD in mice fed the CLA, PHVO, and T7 diets.
The MFD diets decreased the mRNA abundance of genes regulating desaturation (SCD1) and TAG formation (AGPAT1). Rudolph et al. (13) showed that AGPAT1 was the predominant acyl-transferase upregulated for synthesis of TAG in the lactating murine mammary tissue. SCD expression is important for the synthesis of monounsaturated FA essential for lipogenesis or TAG synthesis (25) . Of the 4 known SCD isoforms in mice, SCD1 and SCD2 preferentially desaturate 16:0 and 18:0 FA (26) . The substantial (;60%) conversion of trans-7 18:1 to trans-7, cis-9 CLA, coupled with increased SCD2 mRNA expression, could suggest that the desaturation of trans-7 18:1 to trans-7, cis-9 CLA was regulated by the SCD2 gene isoform. The effects of PHVO were different from other trans-18:1 FA treatments but were similar to that of CLA. This was probably due to the presence of trans-10 18:1 in PHVO. We recently observed that the effects of trans-10 18:1 on lipogenic genes in mammary epithelial cells (MacT) were similar to those of trans-10, cis-12 CLA (15). The lack of an effect of the T9 and T11 diets on the mammary lipogenic gene expression was consistent with their inability to alter milk fat content.
We measured the FA profile and lipogenic gene expression in liver to determine the dietary effects of tFA on hepatic lipogenesis during lactation. Liver weights increased due to fat accumulation in mice with MFD. The effects of dietary tFA taken up by the liver were different from those in the mammary tissue. The hepatic FA profile in mice with MFD was similar to that observed during nonalcoholic fatty liver disease (27) . A deficiency in the hepatic essential FA content is a characteristic feature of fatty liver (17) and could be a consequence of increased FA oxidation, as unsaturated FA are preferentially oxidized (28) . However, increased FA oxidation due to increased PPARa mRNA expression was not enough to prevent fatty liver in the CLA diet-fed mice. The tFA did not affect the mRNA expression of lipogenic genes, suggesting tissue-specific effects. This also suggests that the FA delivered by the blood TAG-rich lipoproteins were probably responsible for the hepatic FA accumulation (29) .
In conclusion, dietary trans-7 18:1 could lead to MFD in lactating mice. Extensive conversion of trans-7 18:1 to trans-7, cis-9 CLA suggests that the effects of this tFA could have been mediated through its desaturation product. The results also suggested that the differences between the effects of trans-10, cis-12 CLA and other tFA could be attributed to its effects on ChREBP and PPARg, in addition to SREBP-1c and THRSP. However, further functional studies are required to establish the role of these transcriptional regulators in MFD. Lastly, the tFA effects were more pronounced in the mammary tissue than in liver. 
